Approval · Notice of Compliance 3118 · 1998
PENTASPAN: Notice of Compliance 3118
Issued August 21, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3118
- Date
- August 21, 1998
- Company
- Dupont Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Plasma volume expander
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PENTASPAN | 00887110 | Cancelled Post Market |
Medicinal ingredients
- PENTASTARCH 10 G per 100ML
- SODIUM CHLORIDE 900 MG per 100ML